Literature DB >> 9002969

The amino terminal lectin-like domain of thrombomodulin is required for constitutive endocytosis.

E M Conway1, S Pollefeyt, D Collen, M Steiner-Mosonyi.   

Abstract

Thrombomodulin (TM) is a multidomain protein that serves as a cofactor in a major natural anticoagulant system. To further characterize the structure-function of TM, we have transfected COS cells with different truncated forms of TM. In the first form, COS cells expressing TM that lacks the putative signal peptide (17 residues); the lectin-like, hydrophobic N-terminal domain (226 residues); and 12 residues of the first epidermal growth factor (EGF)-like repeat (COSdel.238 cells) were found to function normally with respect to TM transport to the cell surface and thrombin-dependent protein C activation. However, in contrast to wild-type TM, as visually studied by immunofluorescence and immunogold electron microscopy, the COSdel.238 cells did not constitutively internalize anti-TM-TM or thrombin-TM complexes. To identify the region responsible for mediating the endocytic process, deletant forms of TM lacking either the lectin-like region (residues 2-155) or the hydrophobic region of the N-terminal domain (residues 161-202) were expressed in COS cells (COSdel.2-155 and COSdel.161-202, respectively). Protein C cofactor activity was maintained in both cells. Although the COSdel.161-202 cells behaved similarly to wild-type TM-transfected cells, visual studies showed a lack of constitutive internalization of thrombin-TM or anti-TM-TM complexes in the COSdel.2-155 cells. We conclude that the lectin-like domain of human TM serves to regulate cell surface expression of TM via the endocytic route and therefore may also play a major physiologic role in controlling intracellular and extracellular accumulation of thrombin in a variety of biologic systems.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9002969

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  4 in total

1.  Thrombomodulin: a bifunctional modulator of inflammation and coagulation in sepsis.

Authors:  Takayuki Okamoto; Hironobu Tanigami; Koji Suzuki; Motomu Shimaoka
Journal:  Crit Care Res Pract       Date:  2012-02-28

2.  Functional characterization of a STAT3-dependent dendritic cell-derived CD14+ cell population arising upon IL-10-driven maturation.

Authors:  Jelle J Lindenberg; Rieneke van de Ven; Sinéad M Lougheed; Anoek Zomer; Saskia J A M Santegoets; Arjan W Griffioen; Erik Hooijberg; Alfons J M van den Eertwegh; Victor L Thijssen; Rik J Scheper; Dinja Oosterhoff; Tanja D de Gruijl
Journal:  Oncoimmunology       Date:  2013-04-01       Impact factor: 8.110

Review 3.  Dendritic Cell Plasticity in Tumor-Conditioned Skin: CD14(+) Cells at the Cross-Roads of Immune Activation and Suppression.

Authors:  Rieneke van de Ven; Jelle J Lindenberg; Dinja Oosterhoff; Tanja D de Gruijl
Journal:  Front Immunol       Date:  2013-11-25       Impact factor: 7.561

Review 4.  Thrombomodulin and the vascular endothelium: insights into functional, regulatory, and therapeutic aspects.

Authors:  Fiona A Martin; Ronan P Murphy; Philip M Cummins
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-04-19       Impact factor: 4.733

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.